| 1.81 0.09 (5.23%) | 05-10 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.32 | 1-year : | 2.59 |
| Resists | First : | 1.98 | Second : | 2.22 |
| Pivot price | 1.71 |
|||
| Supports | First : | 1.61 | Second : | 1.33 |
| MAs | MA(5) : | 1.75 |
MA(20) : | 1.74  |
| MA(100) : | 1.54 |
MA(250) : | 1.28 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 59.1 |
D(3) : | 46 |
| RSI | RSI(14): 51.4 |
|||
| 52-week | High : | 7.8 | Low : | 0.83 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ VANI ] has closed below upper band by 9.9%. Bollinger Bands are 70.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.82 - 1.83 | 1.83 - 1.84 |
| Low: | 1.74 - 1.75 | 1.75 - 1.76 |
| Close: | 1.8 - 1.81 | 1.81 - 1.82 |
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Mon, 13 May 2024
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Up 18.5% in April - Defense World
Fri, 10 May 2024
Vivani Medical Inc expected to post a loss of 12 cents a share - Earnings Preview - XM
Thu, 09 May 2024
Vivani Medical to Present at TIDES Conference 2024 - Business Wire
Tue, 26 Mar 2024
Vivani Medical: Q4 Earnings Snapshot - Quartz
Wed, 06 Mar 2024
Vivani Medical welcomes industry veteran to board By Investing.com - Investing.com
Wed, 06 Mar 2024
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 55 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 45.5 (%) |
| Held by Institutions | 6.1 (%) |
| Shares Short | 698 (K) |
| Shares Short P.Month | 871 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.4 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -34.8 % |
| Return on Equity (ttm) | -78.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.49 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -24 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -3.62 |
| PEG Ratio | 0 |
| Price to Book value | 4.41 |
| Price to Sales | 0 |
| Price to Cash Flow | -4.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|